AbbVie (NY: ABBV )
157.54 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Mar 27, 2023 Add to My Watchlist
All News about AbbVie
AbbVie (ABBV) Q2 2021 Earnings Call Transcript
July 31, 2021
Stock Market Rally Pauses Near Highs Amid Earnings From Apple, Microsoft, Tesla, Amazon, Google, Facebook
July 30, 2021
The market rally paused on the key indexes amid earnings from Apple, Tesla and Amazon. But several stocks flashed buy signals.
Exposures Interest Rates US Equities
AbbVie Inc (NYSE: ABBV) reports Q2 adjusted EPS of $3.11, marginally beating the consensus of $3.09. Overall sales increased 33.9% Y/Y to $13.9 billion, slightly ahead...
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Allergan Shares Updated Data From Vision Loss Candidate Showing Significant Improvement In Near-Vision Reading
July 26, 2021
Allergan, a unit of AbbVie Inc (NYSE: ABBV), has announced new data, including the full results from the Phase 3 GEMINI 1 study of AGN-190584 (pilocarpine 1.25%)...
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
AbbVie - Roche's Venclexta Receives Breakthrough Therapy Tag In High-Risk Myelodysplastic Syndromes
July 21, 2021
The FDA has granted Breakthrough Therapy Designation (BTD) to Venclexta (venetoclax) combined with azacitidine for the potential treatment of adult patients with...
Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight
July 20, 2021
Drug stocks popped Tuesday on reports they could pay $21 billion to settle claims they helped fuel the nation's opioid epidemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following